Virtual Reality Exposure Therapy for Social Phobia

Award Information
Agency: Department of Health and Human Services
Branch: N/A
Contract: 2R42MH060506-02A1
Agency Tracking Number: MH060506
Amount: $0.00
Phase: Phase I
Program: STTR
Awards Year: 2004
Solicitation Year: N/A
Solicitation Topic Code: N/A
Solicitation Number: N/A
Small Business Information
VIRTUALLY BETTER, INC.
VIRTUALLY BETTER, INC., 2450 LAWRENCEVILLE HWY, STE 101, DECATUR, GA, 30033
DUNS: N/A
HUBZone Owned: N
Woman Owned: N
Socially and Economically Disadvantaged: N
Principal Investigator
 PAGE ANDERSON
 (404) 873-4404
 ANDERSON@VIRTUALLYBETTER.COM
Business Contact
 KEN GRAAP
Phone: (404) 634-3400
Email: GRAAP@VIRTUALLYBETTER.COM
Research Institution
 GEORGIA STATE UNIVERSITY
 GEORGIA STATE UNIVERSITY
Atlanta, GA, 30303
 Nonprofit college or university
Abstract
DESCRIPTION (provided by applicant): Individuals with social phobia are less educated, less likely to be married, and are of a lower socioeconomic status (Schneier et al, 1992; Stein & Kean, 2000). Public speaking appears to be the most commonly feared social situation among socially phobic individuals, as well as the general population. Cognitive-behavioral treatments for social anxiety are effective, although exposure to public speaking fears is difficult to arrange unless done in the context of group therapy. A virtual audience as a tool for exposure therapy has the potential to reduce the burden on the therapist in arranging exposures and to offer an alternative for individuals who do not want group therapy. The utilization of a virtual audience represents a significant advance in the use of virtual reality for virtual reality exposure therapy (VRE) in the treatment of anxiety because it is the first attempt to use virtual reality to treat an interpersonal fear. During Phase I, a virtual small group audience and virtual large group audience was developed, and a treatment manual was written and utilized within an open clinical trial (N=10). After treatment, participants reported significant reductions in public speaking fears, as measured by standardized questionnaires. During a post-treatment speech to an actual audience, participants were rated as performing better and looking less anxious than during a pretreatment speech. This STTR Phase II project aims to revise the virtual audience, revise the treatment manual and to employ a randomized clinical trial to compare virtual reality exposure therapy to an empirically supported exposure group treatment and a wait list control group (WL) for the treatment of public speaking anxiety (N=75). Standardized treatment, independent assessment, homogenous DSM-IV inclusion criteria, and randomized assignment to treatment will assure a methodologically rigorous study. Furthermore, the treatment study will take place at a site independent from the site where the virtual audience was developed.

* information listed above is at the time of submission.

Agency Micro-sites

SBA logo
Department of Agriculture logo
Department of Commerce logo
Department of Defense logo
Department of Education logo
Department of Energy logo
Department of Health and Human Services logo
Department of Homeland Security logo
Department of Transportation logo
Environmental Protection Agency logo
National Aeronautics and Space Administration logo
National Science Foundation logo
US Flag An Official Website of the United States Government